# AgeX Therapeutics Inc. (AGE)

Source: https://www.quantisnow.com/company/AGE
Generated: 2026-11-08T02:18:46.855Z

- Ticker: AGE
- Exchange: AMEX
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: agexinc.com

## About

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. Its lead drug-based therapeutic candidate in discovery is AGEX-iTR1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. In addition, the company markets human embryonic stem cells; and GeneCards Database Suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. AgeX Therapeutics, Inc. has a research collaboration with the University of California, Irvine on neural stem cell research program for Huntington's disease and other neurological disorders; a collaboration with Sernova Corp.; and a research collaboration with The Ohio State University using AgeX's brown adipocyte tissue cell therapy candidate AgeX-BAT1 in mice to determine whether transplantation of AgeX-BAT1 cells may improve diet-induced obesity, metabolic health, and cardiac function. The company was founded in 2017 and is based in Alameda, California.

## Latest AGE news and filings

- 2024-05-14 20:25 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5489529)
- 2024-05-14 20:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by AgeX Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-agex-therapeutics-inc-5489383)
- 2024-05-03 21:25 UTC [SEC Form S-1] [SEC Form S-1 filed by AgeX Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-agex-therapeutics-inc-5459813)
- 2024-05-03 20:42 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-changes-in-registrants-5459365)
- 2024-04-17 22:01 UTC [SEC Form 4] [SEC Form 4 filed by Gill Simba](https://www.quantisnow.com/insight/sec-form-4-filed-by-gill-simba-5416714)
- 2024-04-17 20:57 UTC [SEC Form 3] [SEC Form 3 filed by new insider Gill Simba](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-gill-simba-5416454)
- 2024-04-17 20:22 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-financial-statements-and-5416186)
- 2024-04-04 21:18 UTC [SEC Form 4] [SEC Form 4 filed by Bailey Gregory](https://www.quantisnow.com/insight/sec-form-4-filed-by-bailey-gregory-5393358)
- 2024-04-04 00:59 UTC [SEC Form 4] [SEC Form 4 filed by Mintz Steven](https://www.quantisnow.com/insight/sec-form-4-filed-by-mintz-steven-5390787)
- 2024-04-04 00:58 UTC [SEC Form 4] [SEC Form 4 filed by Marshall Richard Peter](https://www.quantisnow.com/insight/sec-form-4-filed-by-marshall-richard-peter-5390785)
- 2024-04-04 00:56 UTC [SEC Form 4] [SEC Form 4 filed by Harris J Milton](https://www.quantisnow.com/insight/sec-form-4-filed-by-harris-j-milton-5390782)
- 2024-04-04 00:55 UTC [SEC Form 4] [SEC Form 4 filed by Gross Remy](https://www.quantisnow.com/insight/sec-form-4-filed-by-gross-remy-5390781)
- 2024-04-04 00:26 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by AgeX Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-agex-therapeutics-inc-5390735)
- 2024-04-04 00:08 UTC [SEC Form 3] [New insider Viegas Tacey claimed ownership of 58,610 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-viegas-tacey-claimed-ownership-of-58610-shares-sec-5390685)
- 2024-04-04 00:07 UTC [SEC Form 3] [SEC Form 3 filed by new insider Moreadith Randall](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-moreadith-randall-5390678)
- 2024-04-04 00:05 UTC [SEC Form 3] [SEC Form 3 filed by new insider Marshall Richard Peter](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-marshall-richard-peter-5390672)
- 2024-04-04 00:02 UTC [SEC Form 3] [New insider Ledger Steven A claimed ownership of 227,927 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-ledger-steven-a-claimed-ownership-of-227927-shares-5390661)
- 2024-04-03 23:59 UTC [SEC Form 3] [SEC Form 3 filed by new insider Harris J Milton](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-harris-j-milton-5390622)
- 2024-04-03 23:55 UTC [SEC Form 3] [SEC Form 3 filed by new insider Gross Remy](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-gross-remy-5390610)
- 2024-04-01 21:27 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-completion-of-acquisition-5381959)
- 2024-03-26 20:03 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by AgeX Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-agex-therapeutics-inc-amendment-5369278)
- 2024-03-22 21:28 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5364544)
- 2024-03-22 21:27 UTC [SEC Form 10-K] [SEC Form 10-K filed by AgeX Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-agex-therapeutics-inc-5364543)
- 2024-03-22 21:27 UTC [AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results](https://www.quantisnow.com/insight/agex-therapeutics-reports-fourth-quarter-and-annual-2023-financial-results-5364533)
- 2024-03-14 20:12 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-material-modification-to-5345046)
- 2024-03-07 21:49 UTC [SEC Form 425] [SEC Form 425 filed by AgeX Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-agex-therapeutics-inc-5327722)
- 2024-03-07 21:47 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-creation-of-a-5327693)
- 2024-03-07 12:47 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by AgeX Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-agex-therapeutics-inc-amendment-5325228)
- 2024-02-14 21:15 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5263522)
- 2024-02-14 21:11 UTC [SEC Form 424B3] [SEC Form 424B3 filed by AgeX Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-agex-therapeutics-inc-5263292)
- 2024-02-14 21:01 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by AgeX Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-agex-therapeutics-inc-amendment-5262807)
- 2024-02-14 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by AgeX Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-agex-therapeutics-inc-5258739)
- 2024-02-07 03:00 UTC [SEC Form S-4] [SEC Form S-4/A filed by AgeX Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-agex-therapeutics-inc-amendment-5235230)
- 2024-02-06 21:05 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Other Events](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-creation-of-a-5233856)
- 2024-02-05 12:19 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by AgeX Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-agex-therapeutics-inc-amendment-5228390)
- 2024-01-25 12:50 UTC [Market Insight] [Why IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-ibm-shares-are-trading-higher-by-over-7-here-5206462)
- 2024-01-19 21:05 UTC [SEC Form 8-K] [AgeX Therapeutics Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/agex-therapeutics-inc-filed-sec-form-8-k-creation-of-a-5196353)
- 2024-01-18 22:29 UTC [SEC Form 3] [New insider Mintz Steven claimed ownership of 116,324 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-mintz-steven-claimed-ownership-of-116324-shares-sec-5194628)
- 2024-01-17 21:19 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by AgeX Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-agex-therapeutics-inc-amendment-5191556)
- 2024-01-16 14:11 UTC [SEC Form S-4] [SEC Form S-4/A filed by AgeX Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-4a-filed-by-agex-therapeutics-inc-amendment-5187900)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AGE
- Earnings history: https://www.quantisnow.com/earnings/AGE
- Dividend history: https://www.quantisnow.com/dividends/AGE
- Insider transactions: https://www.quantisnow.com/insiders/AGE
- Options chain: https://www.quantisnow.com/options/AGE
- SEC 8-K filings only: https://www.quantisnow.com/company/AGE/8-k
- RSS and alerts for AGE: https://www.quantisnow.com/docs/rss-feeds.md